Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-25T00:38:25.669Z Has data issue: false hasContentIssue false
  • English
  • Français

TEGRETOL

Published online by Cambridge University Press:  18 September 2015

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Other
Information
Canadian Journal of Neurological Sciences , Volume 23 , Issue S1: 31st MEETING OF THE CANADIAN CONGRESS OF NEUROLOGICAL SCIENCES , May 1996 , pp. S93 - S94
Copyright
Copyright © Canadian Neurological Sciences Federation 1996

References

REFERENCES

1.Smith, DBet al: Results of a nationwide veterans administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987; 28(Suppl 3): 550–558.CrossRefGoogle ScholarPubMed
2.Reynolds, EH. Polytherapy, monotherapy, and carbamazepine. Epilepsia 1987; 28 (Suppl 3): 577–580.CrossRefGoogle ScholarPubMed
3.Aldenkamp, et al: Controlled release carbamazepine: cognitive side effects in patients with epilepsy. Epilepsia 1987; 28(Suppl 3): 507–514.CrossRefGoogle ScholarPubMed
4.TEGRETOL® Product Monograph, November, 1995.Google Scholar